Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Altana Pharma AG v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2009)

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix®. The active ingredient of Protonix® is the compound pantoprazole, which belongs to a class of compounds known as proton pump inhibitors ("PPI") that are used to treat gastric acid disorders in the stomach. A predecessor company to AstraZeneca began commercializing the first PPI compound, omeprazole, in 1989 under the...

Full post as published by Patent Docs on May 18, 2009 (boomark / email).